Optimizing T-cell receptor gene therapy for hematologic malignancies.

Optimizing T-cell receptor gene therapy for hematologic malignancies.

Item
http://www.wikidata.org/entity/Q38840466
Immunotherapy for opportunistic infections: Current status and future perspectives.Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer.Recent advances in T-cell immunotherapy for haematological malignancies.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Tumor-targeting domains for chimeric antigen receptor T cells.Delivery technologies for genome editing.T cells expressing chimeric antigen receptor promote immune tolerance.Safety strategies of genetically engineered T cells in cancer immunotherapy.CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.Treating hematological malignancies with cell therapy: where are we now?Engineering chimeric antigen receptor-T cells for cancer treatment.New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
P2860

Optimizing T-cell receptor gene therapy for hematologic malignancies.

Item
http://www.wikidata.org/entity/Q38840466
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Optimizing T-cell receptor gene therapy for hematologic malignancies.
@en
type
label
Optimizing T-cell receptor gene therapy for hematologic malignancies.
@en
prefLabel
Optimizing T-cell receptor gene therapy for hematologic malignancies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Optimizing T-cell receptor gene therapy for hematologic malignancies
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2015-11-629071
P407
P433
P478
P50
P577
P698
P921
P932